These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29683119)

  • 21. Costs Cast Shadow on Optimism about Treatment.
    Manag Care; 2016 Oct; 25(10):29. PubMed ID: 28121542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness, cancer burden and financial crisis: a perfect storm.
    Belda-Iniesta C
    Clin Transl Oncol; 2012 Oct; 14(10):713-4. PubMed ID: 22996423
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Financial Toxicity: A Review of the Literature and Nursing Opportunities.
    Thomas T; Hughes T; Mady L; Belcher SM
    Clin J Oncol Nurs; 2019 Oct; 23(5):5-13. PubMed ID: 31538991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and health economic challenges of personalized medicine].
    Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerating the delivery of patient-centered, high-quality cancer care.
    Abrahams E; Foti M; Kean MA
    Clin Cancer Res; 2015 May; 21(10):2263-7. PubMed ID: 25901079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Biotherapy of Cancer-VI. Proceedings of a symposium. San Diego, California, May 15, 1992.
    Semin Oncol Nurs; 1992 Nov; 8(4 Suppl 1):1-28. PubMed ID: 1361071
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor control versus adverse events with targeted anticancer therapies.
    Keefe DM; Bateman EH
    Nat Rev Clin Oncol; 2011 Dec; 9(2):98-109. PubMed ID: 22182972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial Toxicity: Management as an Adverse Effect of Cancer Treatment
.
    Fessele KL
    Clin J Oncol Nurs; 2017 Dec; 21(6):762-764. PubMed ID: 29149134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financial Toxicity.
    Nogueira LA; Lenhani BE; Tomim DH; Kalinke LP
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):289-293. PubMed ID: 32102501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer, poverty and human development: challenges for nursing care in oncology.
    Batalha de Menezes Mde F; Camargo TC; dos Santos Guedes MT; Lós de Alcântara LF
    Rev Lat Am Enfermagem; 2007; 15 Spec No():780-5. PubMed ID: 17934585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost of getting personal.
    Nat Med; 2019 Dec; 25(12):1797. PubMed ID: 31806890
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Pathways: Recommendations for Putting Patients at the Center of Value-Based Care.
    Abrahams E; Balch A; Goldsmith P; Kean M; Miller AM; Omenn G; Sonet E; Sprandio J; Tyne C; Westrich K
    Clin Cancer Res; 2017 Aug; 23(16):4545-4549. PubMed ID: 28652243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspective: The precision-oncology illusion.
    Prasad V
    Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.
    Doble B; John T; Thomas D; Fellowes A; Fox S; Lorgelly P
    Lung Cancer; 2017 May; 107():22-35. PubMed ID: 27316470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncology Home Care Service.
    Hafenbrack A; Nussbaumer I; Stoll H; Weber W
    Support Care Cancer; 1998 May; 6(3):195-6. PubMed ID: 9629869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Let's Talk About Sex. Handling Sensitive Conversations With Tact and Finesse.
    Christensen D
    ONS Connect; 2015 Sep; 30(3):24-8. PubMed ID: 26449117
    [No Abstract]   [Full Text] [Related]  

  • 38. Let's talk about cytotoxic chemotherapy dosing: unravelling adjustments and off-protocol prescribing.
    Tjokrowidjaja A; Hovey E; Lewis CR
    Med J Aust; 2019 Feb; 210(2):65-66. PubMed ID: 30712300
    [No Abstract]   [Full Text] [Related]  

  • 39. Economic Impact Among Family Caregivers of Patients With Advanced Ovarian Cancer.
    Angioli R; Capriglione S; Aloisi A; Miranda A; de Cicco Nardone C; Terranova C; Adrower R; Plotti F
    Int J Gynecol Cancer; 2015 Oct; 25(8):1541-6. PubMed ID: 26270119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The financial burden of cancer care: do patients in the US know what to expect?
    Peppercorn J
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):835-42. PubMed ID: 25269513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.